Cardiol Therapeutics (CRDL) Depreciation and Depletion (2020 - 2026)
Cardiol Therapeutics' (CRDL) quarterly Depreciation and Depletion came in at $19476.4 in Q1 2026, up 11.85% YoY from $17413.2 in Q1 2025, and up 4.56% on a QoQ basis from $18627.0 in Q4 2025.
Cardiol Therapeutics (CRDL) Depreciation and Depletion (2020 - 2026) Analysis & Trends
Cardiol Therapeutics (CRDL) has 7 years of Depreciation and Depletion data on file, last reported at $19476.4 in Q1 2026.
- Quarterly Depreciation and Depletion rose 11.85% year-over-year to $19476.4 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $75051.7 (down 29.27% YoY) and the FY2025 annual result came in at $73130.6, down 37.23% from the prior year.
- Depreciation and Depletion improved to $19476.4 in Q1 2026, from $18627.0 in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $34713.7 in Q4 2024 to a low of $17413.2 in Q1 2025.
- A 5-year average of $25691.7 and a median of $25665.1 in 2022 frame the typical range for Depreciation and Depletion.
- Annual changes were most pronounced in 2023 — Depreciation and Depletion rose 27.66% — and 2025, when it tumbled 46.34%.
- Tracing CRDL's Depreciation and Depletion over 5 years: stood at $27201.3 in 2022, then gained by 23.27% to $33531.5 in 2023, then rose by 3.53% to $34713.7 in 2024, then plunged by 46.34% to $18627.0 in 2025, then rose by 4.56% to $19476.4 in 2026.
- The last three Depreciation and Depletion figures came in at $19476.4 (Q1 2026), $18627.0 (Q4 2025), and $18566.3 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Cardiol Therapeutics | 215.50 Mn | 196.65 Mn | - | 8,346.90 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19,476.35 |
| Mar 31, 2026 | 19,476.35 |
| Dec 31, 2025 | 18,627.03 |
| Dec 31, 2025 | 18,627.03 |
| Sep 30, 2025 | 18,566.25 |
| Sep 30, 2025 | 18,566.25 |
| Jun 30, 2025 | 18,382.02 |
| Jun 30, 2025 | 18,382.02 |
| Mar 31, 2025 | 17,413.16 |
| Mar 31, 2025 | 17,413.16 |
| Dec 31, 2024 | 34,713.67 |
| Dec 31, 2024 | 34,713.67 |
| Sep 30, 2024 | 24,157.04 |
| Sep 30, 2024 | 24,157.04 |
| Jun 30, 2024 | 29,828.34 |
| Jun 30, 2024 | 29,828.34 |
| Mar 31, 2024 | 30,064.49 |
| Mar 31, 2024 | 30,064.49 |
| Dec 31, 2023 | 33,531.55 |
| Dec 31, 2023 | 33,531.55 |